Ledger.Open graph →
SEC Form D · filed July 15, 2022

CorriXR Therapeutics, Inc

Offering
$8.0M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Eric Kmiec · Wilmington, DEExec · DirectorJeffrey Carper · Wilmington, DEDirectorJanice Nevin · Wilmington, DEDirectorEric Kmiec · Wilmington, DEExec · DirectorJeffrey Carper · Wilmington, DEDirectorJanice Nevin · Wilmington, DEDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗